vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and WM TECHNOLOGY, INC. (MAPS). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $43.1M, roughly 2.0× WM TECHNOLOGY, INC.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -8.3%, a 31.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -9.7%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-280.0K). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -1.5%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

WM Entertainment is a South Korean entertainment company established in 2008 by former singer Lee Won-min. The company is responsible for managing artist Oh My Girl. On April 7, 2021, the company was acquired by RBW.

FDMT vs MAPS — Head-to-Head

Bigger by revenue
FDMT
FDMT
2.0× larger
FDMT
$85.1M
$43.1M
MAPS
Growing faster (revenue YoY)
FDMT
FDMT
+8508909.7% gap
FDMT
8508900.0%
-9.7%
MAPS
Higher net margin
FDMT
FDMT
31.1% more per $
FDMT
22.8%
-8.3%
MAPS
More free cash flow
FDMT
FDMT
$28.8M more FCF
FDMT
$28.5M
$-280.0K
MAPS
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
-1.5%
MAPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
MAPS
MAPS
Revenue
$85.1M
$43.1M
Net Profit
$19.4M
$-3.6M
Gross Margin
94.9%
Operating Margin
17.3%
-13.5%
Net Margin
22.8%
-8.3%
Revenue YoY
8508900.0%
-9.7%
Net Profit YoY
139.1%
-251.9%
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
MAPS
MAPS
Q4 25
$85.1M
$43.1M
Q3 25
$90.0K
$42.2M
Q2 25
$15.0K
$44.8M
Q1 25
$14.0K
$44.6M
Q4 24
$1.0K
$47.7M
Q3 24
$3.0K
$46.6M
Q2 24
$5.0K
$45.9M
Q1 24
$28.0K
$44.4M
Net Profit
FDMT
FDMT
MAPS
MAPS
Q4 25
$19.4M
$-3.6M
Q3 25
$-56.9M
$2.5M
Q2 25
$-54.7M
$1.4M
Q1 25
$-48.0M
$1.6M
Q4 24
$2.4M
Q3 24
$-43.8M
$3.3M
Q2 24
$-35.0M
$716.0K
Q1 24
$-32.4M
$1.2M
Gross Margin
FDMT
FDMT
MAPS
MAPS
Q4 25
94.9%
Q3 25
95.0%
Q2 25
94.9%
Q1 25
95.0%
Q4 24
95.2%
Q3 24
95.3%
Q2 24
95.1%
Q1 24
94.8%
Operating Margin
FDMT
FDMT
MAPS
MAPS
Q4 25
17.3%
-13.5%
Q3 25
-67983.3%
4.6%
Q2 25
-396373.3%
4.4%
Q1 25
-383007.1%
5.9%
Q4 24
9.6%
Q3 24
-1704400.0%
11.2%
Q2 24
-849120.0%
2.7%
Q1 24
-136200.0%
8.5%
Net Margin
FDMT
FDMT
MAPS
MAPS
Q4 25
22.8%
-8.3%
Q3 25
-63195.6%
5.8%
Q2 25
-364386.7%
3.2%
Q1 25
-342657.1%
3.7%
Q4 24
4.9%
Q3 24
-1461433.3%
7.2%
Q2 24
-699060.0%
1.6%
Q1 24
-115717.9%
2.8%
EPS (diluted)
FDMT
FDMT
MAPS
MAPS
Q4 25
$0.43
Q3 25
$-1.01
Q2 25
$-0.98
Q1 25
$-0.86
$0.02
Q4 24
Q3 24
$-0.79
Q2 24
$-0.63
Q1 24
$-0.66
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
MAPS
MAPS
Cash + ST InvestmentsLiquidity on hand
$402.7M
$62.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$57.2M
Total Assets
$566.7M
$190.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
MAPS
MAPS
Q4 25
$402.7M
$62.4M
Q3 25
$305.1M
Q2 25
$293.2M
Q1 25
$321.4M
Q4 24
$424.9M
$52.0M
Q3 24
$501.9M
Q2 24
$541.9M
Q1 24
$525.9M
Stockholders' Equity
FDMT
FDMT
MAPS
MAPS
Q4 25
$505.7M
$57.2M
Q3 25
$369.0M
$56.9M
Q2 25
$420.9M
$52.7M
Q1 25
$469.7M
$48.5M
Q4 24
$510.6M
$36.1M
Q3 24
$552.9M
$29.5M
Q2 24
$588.3M
$24.5M
Q1 24
$600.6M
$20.8M
Total Assets
FDMT
FDMT
MAPS
MAPS
Q4 25
$566.7M
$190.7M
Q3 25
$424.0M
$192.9M
Q2 25
$473.6M
$188.1M
Q1 25
$515.7M
$183.8M
Q4 24
$560.4M
$181.9M
Q3 24
$604.0M
$173.6M
Q2 24
$620.1M
$168.0M
Q1 24
$629.9M
$165.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
MAPS
MAPS
Operating Cash FlowLast quarter
$28.6M
$3.0M
Free Cash FlowOCF − Capex
$28.5M
$-280.0K
FCF MarginFCF / Revenue
33.5%
-0.7%
Capex IntensityCapex / Revenue
0.1%
7.7%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M
$13.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
MAPS
MAPS
Q4 25
$28.6M
$3.0M
Q3 25
$-46.5M
$6.4M
Q2 25
$-43.4M
$11.1M
Q1 25
$-47.8M
$5.7M
Q4 24
$-134.6M
$9.4M
Q3 24
$-29.4M
$7.2M
Q2 24
$-30.2M
$12.7M
Q1 24
$-29.1M
$7.4M
Free Cash Flow
FDMT
FDMT
MAPS
MAPS
Q4 25
$28.5M
$-280.0K
Q3 25
$-46.6M
$3.6M
Q2 25
$-43.4M
$8.2M
Q1 25
$-48.4M
$2.0M
Q4 24
$-138.4M
$7.3M
Q3 24
$-31.2M
$4.9M
Q2 24
$-30.6M
$10.1M
Q1 24
$-29.8M
$2.9M
FCF Margin
FDMT
FDMT
MAPS
MAPS
Q4 25
33.5%
-0.7%
Q3 25
-51765.6%
8.4%
Q2 25
-289620.0%
18.3%
Q1 25
-345635.7%
4.5%
Q4 24
-13837100.0%
15.2%
Q3 24
-1038966.7%
10.4%
Q2 24
-611840.0%
21.9%
Q1 24
-106421.4%
6.4%
Capex Intensity
FDMT
FDMT
MAPS
MAPS
Q4 25
0.1%
7.7%
Q3 25
101.1%
6.8%
Q2 25
440.0%
6.3%
Q1 25
4507.1%
8.2%
Q4 24
378600.0%
4.5%
Q3 24
59266.7%
5.1%
Q2 24
6980.0%
5.7%
Q1 24
2535.7%
10.2%
Cash Conversion
FDMT
FDMT
MAPS
MAPS
Q4 25
1.47×
Q3 25
2.61×
Q2 25
7.75×
Q1 25
3.44×
Q4 24
4.00×
Q3 24
2.17×
Q2 24
17.67×
Q1 24
5.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FDMT
FDMT

Segment breakdown not available.

MAPS
MAPS

Services$39.5M92%
Other$3.6M8%

Related Comparisons